Graham Capital Management »

Travere Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 22M 1.13
2025-06-30 $40M 42M 0.95
2025-03-31 $21M 21M 1.00
2024-12-31 $36M 38M 0.94
2024-09-30 $13M 16M 0.87

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Eos Energy Enterprises Com Cl A Put Option (EOSE)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tilray Brands Note 5.200% 6/1 (Principal)
Sunrun Note 4.000% 3/0 (Principal)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Rivian Automotive Note 3.625%10/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Henderson Group
Shenkman Capital Management
FMR
BlackRock

View all funds holding Travere Therapeutics